Clarus Corp
For the period ended Jun 30, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 6, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-03-31; filed 2026-05-07.
0001104659-26-057191
Item 1A. Risk FactorsCurrent report: 10-Q
Period ended 2026-06-30; filed 2026-08-06.
0001104659-26-092074
Item 1A. Risk FactorsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 4 previous paragraphs and 6 current paragraphs.
1 unchanged; 1 reworded; 4 added; 2 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
There have been no material changes in our risk factors from those disclosed in Part I, Item 1A. of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and Part II, Item 1A. of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026.
Added paragraphs (4)
Current report
The Company did not sell any securities during the quarter ended June 30, 2026 that were not registered under the Securities Act of 1933, as amended.
Current report
On August 1, 2022, the Company announced that its Board of Directors implemented a stock repurchase program that allows the repurchase of up to $50,000,000 of the Company’s outstanding common stock. During the quarter ended June 30, 2026, the Company purchased 153,331 shares of the Company’s common stock for $447,047 under the Company’s authorized stock repurchase program.
Removed paragraphs (2)
Previous report
Our review of strategic alternatives may not result in any transaction or other strategic outcome and could adversely affect our business, results of operations and stock price.
Previous report
We have announced that our Board of Directors has initiated a review of strategic alternatives to enhance shareholder value. There can be no assurance that this review will result in any transaction or other strategic outcome, or as to the timing, terms, structure or completion of any such transaction or outcome. The review process may involve significant costs, divert management’s attention, disrupt our business and operations, and create uncertainty for our employees, customers, suppliers and other business partners. In addition, any potential transaction or other strategic outcome may be subject to risks and uncertainties, including market conditions, financing availability, regulatory approvals, third-party consents and the negotiation and execution of definitive agreements. We may determine to suspend or terminate the review process at any time, and we do not intend to provide updates regarding the review unless and until our Board of Directors approves a specific transaction or other strategic outcome, or otherwise determines that disclosure is appropriate or required. If the review does not result in a transaction or other strategic outcome, or if any transaction or outcome is delayed, not completed or viewed unfavorably, our business, financial condition, results of operations and stock price could be adversely affected.
Reworded paragraphs (1)
Previous wording
Except as set forth below, there have been no material changes in our risk factors from those disclosed in Part I, Item 1A. of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
Current wording
There have been no material changes in our risk factors from those disclosed in Part I, Item 1A. of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and Part II, Item 1A. of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026.